PROKIDNEY CORP. — Director's Dealing 2023

Dec 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2023-12-03

Reporting Person: Culleton Bruce (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-03	Employee stock option (right to buy)	$1.69	A	2000000	Acquired	2033-12-03	Class A Ordinary Shares (2000000)	Direct

Footnotes

F1: The Exercise Price is equal to the greater of (i) the thirty day average stock price of the Company's Class A Ordinary Shares on the Nasdaq Stock Market ("Nasdaq") as of the date of grant (the "Grant Date") and (ii) the closing price of the Company's Class A Ordinary Shares on Nasdaq as of the Grant Date.

F2: The option vests 25% on the first anniversary of November 15, 2023 and the remaining 75% vests in substantially equal quarterly installments over the following 36 months on each quarterly anniversary of November 15, 2023, subject to continued employment through each such vesting date.